Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8966)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2015 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Boon GJ, Day AS, Mulder CJ, Gearry RB. Are faecal markers good indicators of mucosal healing in inflammatory bowel disease? World J Gastroenterol 2015; 21(40): 11469-11480 [PMID: 26523111 DOI: 10.3748/wjg.v21.i40.11469] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i40/11469.htm |
| Number | Citing Articles |
| 1 |
Ashley Bond, Susanna Dodd, Gareth Fisher, Thomas Skouras, Sreedhar Subramanian. Concurrent immunomodulator therapy is associated with higher adalimumab trough levels during scheduled maintenance therapy. Scandinavian Journal of Gastroenterology 2017; 52(2): 204 doi: 10.1080/00365521.2016.1245777
|
| 2 |
Artem A. Antoshin, Anastasia I. Shpichka, Guilin Huang, Kuo Chen, Pengwei Lu, Andrey A. Svistunov, Alexey V. Lychagin, Marina M. Lipina, Mikhail Y. Sinelnikov, Igor V. Reshetov, Peter S. Timashev. Lactoferrin as a regenerative agent: The old-new panacea?. Pharmacological Research 2021; 167: 105564 doi: 10.1016/j.phrs.2021.105564
|
| 3 |
Dario Sorrentino, Vu Q. Nguyen, Kim Love. Fecal Lactoferrin Predicts Primary Nonresponse to Biologic Agents in Inflammatory Bowel Disease. Digestive Diseases 2021; 39(6): 626 doi: 10.1159/000515432
|
| 4 |
Aude Marchal Bressenot. Which evidence for a treat to target strategy in ulcerative colitis?. Best Practice & Research Clinical Gastroenterology 2018; : 3 doi: 10.1016/j.bpg.2018.05.001
|
| 5 |
Matthew K. Doherty, Tao Ding, Charlie Koumpouras, Shannon E. Telesco, Calixte Monast, Anuk Das, Carrie Brodmerkel, Patrick D. Schloss, Claire M. Fraser. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients. mBio 2018; 9(2) doi: 10.1128/mBio.02120-17
|
| 6 |
Dario Sorrentino, James M Gray. Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2021; 27(8): 1237 doi: 10.1093/ibd/izaa348
|
| 7 |
Emiko Mizoguchi, Renuka Subramaniam, Toshiyuki Okada, Atsushi Mizoguchi. A Review of Selected IBD Biomarkers: From Animal Models to Bedside. Diagnostics 2021; 11(2): 207 doi: 10.3390/diagnostics11020207
|
| 8 |
Kiran K. Motwani, Madeline Alizadeh, Ameer Abutaleb, Jennifer Grossman, Jennifer Wellington, Raymond K. Cross, Kirk Russ, Meena Bewtra, James Lewis, Raymond Cross, Uni Wong, Scott Snapper, Josh Korzenik, Shrinivas Bishu, Rick Duerr, Sumona Saha, Freddy Caldera, Laura Raffals, Richa Shukla, Themistocles Dassopoulos, Matthew Bohm, Poonam Beniwal-Patel, David Hudesman, Lauren Brook, Joel Pekow, Elizabeth Scoville, Matthew Cioba, Parakkal Deepak. Correlation Between Serum and Fecal Biomarkers and Patient-Reported Outcomes in Patients with Crohn’s Disease and Ulcerative Colitis. Digestive Diseases and Sciences 2024; doi: 10.1007/s10620-024-08421-w
|
| 9 |
Darla R. Shores, Allen D. Everett. Children as Biomarker Orphans: Progress in the Field of Pediatric Biomarkers. The Journal of Pediatrics 2018; 193: 14 doi: 10.1016/j.jpeds.2017.08.077
|
| 10 |
Kathryn A Sexton, John R Walker, Laura E Targownik, Lesley A Graff, Clove Haviva, Brooke E Beatie, Sarah K Petty, Matthew T Bernstein, Harminder Singh, Norine Miller, Charles N Bernstein. The Inflammatory Bowel Disease Symptom Inventory: A Patient-report Scale for Research and Clinical Application. Inflammatory Bowel Diseases 2019; 25(8): 1277 doi: 10.1093/ibd/izz038
|
| 11 |
Sreedhar Subramanian, Rebecca Asher, William Weston, Michael Rimmer, Adam McConville, Alex Malin, Richard Jackson, Paul Collins, Chris Probert, Martyn Dibb, Jonathan M. Rhodes. Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use. Inflammatory Bowel Diseases 2016; 22(8): 1902 doi: 10.1097/MIB.0000000000000803
|
| 12 |
Barbara Iwańczak, Małgorzata Ruczka, Małgorzata Matusiewicz, Tomasz Pytrus, Krzysztof Matusiewicz, Elżbieta Krzesiek. Correlation between biomarkers (calprotectin, seromucoid, metalloproteinase-3 and CRP) and clinical and endoscopic activity of ulcerative colitis in children. Advances in Medical Sciences 2020; 65(2): 259 doi: 10.1016/j.advms.2020.03.004
|
| 13 |
Paula Ministro, Diana Martins. Fecal biomarkers in inflammatory bowel disease: how, when and why?. Expert Review of Gastroenterology & Hepatology 2017; 11(4): 317 doi: 10.1080/17474124.2017.1292128
|
| 14 |
Gursimran Kochhar, Bret Lashner. Utility of Biomarkers in the Management of Inflammatory Bowel Disease. Current Treatment Options in Gastroenterology 2017; 15(1): 105 doi: 10.1007/s11938-017-0129-z
|
| 15 |
Andrew S. Day, Mustafa Adamji. Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease. Frontiers in Pediatrics 2017; 5 doi: 10.3389/fped.2017.00133
|
| 16 |
Paulina Nuñez F, Uma Mahadevan, Rodrigo Quera, Constanza Bay, Patricio Ibañez. Treat-to-target approach in the management of inflammatory Bowel disease. Gastroenterología y Hepatología 2021; 44(4): 312 doi: 10.1016/j.gastrohep.2020.06.032
|
| 17 |
Cong Dai, Min Jiang, Ming-Jun Sun. Fecal markers in the management of inflammatory bowel disease. Postgraduate Medicine 2018; 130(7): 597 doi: 10.1080/00325481.2018.1503919
|
| 18 |
Alexandre Jentzer, Anne-Emmanuelle Depincé-Berger, Christian Genin, Xavier Roblin, Stéphane Paul. Nouveaux marqueurs diagnostiques et pronostiques des maladies chroniques inflammatoires intestinales. Revue Francophone des Laboratoires 2016; 2016(484): 49 doi: 10.1016/S1773-035X(16)30223-4
|
| 19 |
F Magro, J Sabino, F Rosini, M Tripathi, P Borralho, P Baldin, S Danese, A Driessen, I O Gordon, M Iacucci, N Noor, M Svrcek, L Peyrin-Biroulet, R Feakins. ECCO Position on Harmonisation of Crohn’s Disease Mucosal Histopathology. Journal of Crohn's and Colitis 2022; 16(6): 876 doi: 10.1093/ecco-jcc/jjac006
|
| 20 |
Glen Doherty, Konstantinos H Katsanos, Johan Burisch, Matthieu Allez, Konstantinos Papamichael, Andreas Stallmach, Ren Mao, Ingrid Prytz Berset, Javier P Gisbert, Shaji Sebastian, Jarosław Kierkuś, Loris Lopetuso, Edyta Szymanska, Edouard Louis. European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2018; 12(1): 17 doi: 10.1093/ecco-jcc/jjx101
|
| 21 |
Marisa Iborra, Belén Beltrán, Pilar Nos. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America 2016; 26(4): 641 doi: 10.1016/j.giec.2016.06.005
|
| 22 |
Fang Chen, Yue Hu, Yi-Hong Fan, Bin Lv. Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.679264
|
| 23 |
Paulina Nuñez F, Uma Mahadevan, Rodrigo Quera, Constanza Bay, Patricio Ibañez. Treat-to-target approach in the management of inflammatory Bowel disease. Gastroenterología y Hepatología (English Edition) 2021; 44(4): 312 doi: 10.1016/j.gastre.2020.06.023
|
| 24 |
Hu Zhang, Zhen Zeng, Arjudeb Mukherjee, Bo Shen. Molecular diagnosis and classification of inflammatory bowel disease. Expert Review of Molecular Diagnostics 2018; 18(10): 867 doi: 10.1080/14737159.2018.1516549
|
| 25 |
David Díaz-Jiménez, Marjorie De la Fuente, Karen Dubois-Camacho, Glauben Landskron, Janitza Fuentes, Tamara Pérez, María Julieta González, Daniela Simian, Marcela A. Hermoso, Rodrigo Quera. Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0520-6
|
| 26 |
Giulia D'Arcangelo, Salvatore Oliva, Anna Dilillo, Franca Viola, Fortunata Civitelli, Sara Isoldi, Salvatore Cucchiara, Marina Aloi. Predictors of Long‐term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab. Journal of Pediatric Gastroenterology and Nutrition 2019; 68(6): 841 doi: 10.1097/MPG.0000000000002262
|
| 27 |
Joel Tan Joel Tan, Teresa Neeman, Kavitha Subramaniam Kavitha Subramaniam. The utility of serum anti-tumour necrosis factor levels and biomarkers in predicting endoscopic activity in inflammatory bowel disease. Gastroenterology & Hepatology: Open Access 2022; 13(2): 53 doi: 10.15406/ghoa.2022.13.00494
|
| 28 |
Brian Yan, Brian Feagan, Anouar Teriaky, Mahmoud Mosli, Rachid Mohamed, Geoff Williams, Elaine Yeung, Elaine Yong, Aaron Haig, Michael Sey, Larry Stitt, GY Zou, Vipul Jairath. Reliability of EUS indices to detect inflammation in ulcerative colitis. Gastrointestinal Endoscopy 2017; 86(6): 1079 doi: 10.1016/j.gie.2017.07.035
|
| 29 |
Chandni Patel, Ladina Keller, Sophie Welsche, Jan Hattendorf, Somphou Sayasone, Said M. Ali, Shaali M. Ame, Jean Tenena Coulibaly, Eveline Hürlimann, Jennifer Keiser. Assessment of fecal calprotectin and fecal occult blood as point-of-care markers for soil-transmitted helminth attributable intestinal morbidity in a case-control substudy conducted in Côte d'Ivoire, Lao PDR and Pemba Island, Tanzania. EClinicalMedicine 2021; 32: 100724 doi: 10.1016/j.eclinm.2021.100724
|
| 30 |
Almina Jukic, Latifa Bakiri, Erwin F. Wagner, Herbert Tilg, Timon E. Adolph. Calprotectin: from biomarker to biological function. Gut 2021; 70(10): 1978 doi: 10.1136/gutjnl-2021-324855
|
| 31 |
Brian M. Yan, Michael S.L. Sey, Paul Belletrutti, Gary Brahm, Leonardo Guizzetti, Vipul Jairath. Reliability of the Endoscopic Ultrasound Ulcerative Colitis (EUS-UC) score for assessment of inflammation in patients with ulcerative colitis. Endoscopy International Open 2021; 9(07): E1116 doi: 10.1055/a-1481-8032
|
| 32 |
Mayu Uchihara, Jun Kato, Saya Tsuda, Takeichi Yoshida, Takao Maekita, Mikitaka Iguchi, Masayuki Kitano. Blood biomarkers reflect integration of severity and extent of endoscopic inflammation in ulcerative colitis. JGH Open 2017; 1(3): 98 doi: 10.1002/jgh3.12017
|
| 33 |
Kuo Chen, Jin Zhang, Narasimha M. Beeraka, Jialing Li, Mikhail Y. Sinelnikov, Xinliang Zhang, Yu Cao, Darya K. Zakharova, Vladimir N. Nikolenko, Igor V. Reshetov, Pengwei Lu. Novel Perspectives on Nanotechnological and Biomedical Implications of
Monotherapy or Combination Regimen of Lactoferrin. Current Pharmaceutical Design 2023; 29(20): 1579 doi: 10.2174/1381612829666230622140926
|
| 34 |
Hai Yun Shi, Francis K. L Chan, Anthony W. H Chan, Akira Higashimori, Moe Kyaw, Jessica Y. L Ching, Arthur K. C Luk, Sunny H Wong, Justin C. Y Wu, Joseph J. Y Sung, Siew C Ng. Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores. Journal of Crohn's and Colitis 2017; 11(9): 1071 doi: 10.1093/ecco-jcc/jjx088
|
| 35 |
Wojciech Marlicz, Karolina Skonieczna-Żydecka, Konstantinos John Dabos, Igor Łoniewski, Anastasios Koulaouzidis. Emerging concepts in non-invasive monitoring of Crohn’s disease. Therapeutic Advances in Gastroenterology 2018; 11: 175628481876907 doi: 10.1177/1756284818769076
|
| 36 |
Christopher Ma, Rowan Lumb, Emily V. Walker, Rae R. Foshaug, ThucNhi T. Dang, Sanam Verma, Vivian W. Huang, Karen I. Kroeker, Karen Wong, Levinus A. Dieleman, Richard N. Fedorak, Brendan P. Halloran. Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2017; 23(9): 1643 doi: 10.1097/MIB.0000000000001173
|
| 37 |
Yuko Okuyama, Yosuke Doi, Naoto Matsuyama, Michiyo Uchino, Takayuki Yamamoto. A novel sol particle immunoassay for fecal calprotectin in inflammatory bowel disease patients. Clinica Chimica Acta 2016; 456: 1 doi: 10.1016/j.cca.2016.02.012
|
| 38 |
Cong Dai, Min Jiang, Ming‐Jun Sun, Qin Cao. Fecal immunochemical test for predicting mucosal healing in ulcerative colitis patients: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2018; 33(5): 990 doi: 10.1111/jgh.14121
|
| 39 |
Fumihiko Iwamoto, Katsuyoshi Matsuoka, Maiko Motobayashi, Kento Takenaka, Toru Kuno, Keisuke Tanaka, Yuya Tsukui, Shoji Kobayashi, Takashi Yoshida, Toshimitsu Fujii, Eiko Saito, Tatsuya Yamaguchi, Masakazu Nagahori, Tadashi Sato, Kazuo Ohtsuka, Nobuyuki Enomoto, Mamoru Watanabe. Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon‐assisted endoscopy. Journal of Gastroenterology and Hepatology 2018; 33(12): 1984 doi: 10.1111/jgh.14310
|
| 40 |
Alexandre Carvalho, Jacky Lu, Jamisha D. Francis, Rebecca E. Moore, Kathryn P. Haley, Ryan S. Doster, Steven D. Townsend, Jeremiah G. Johnson, Steven M. Damo, Jennifer A. Gaddy. S100A12 in Digestive Diseases and Health: A Scoping Review. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/2868373
|
| 41 |
Sabrina Cenni, Marianna Casertano, Marco Trani, Daniela Pacella, Massimo Martinelli, Annamaria Staiano, Erasmo Miele, Caterina Strisciuglio. The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study. European Journal of Pediatrics 2023; 182(3): 1299 doi: 10.1007/s00431-022-04771-7
|